- CA$50.78m
- CA$44.56m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.24 | 6.03 | 13.9 | 11.2 | 5.53 |
Operating Profit | -6.24 | -6.03 | -13.9 | -11.2 | -5.53 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.23 | -5.5 | -12.7 | -10 | -3.19 |
Net Income After Taxes | 9.23 | -5.5 | -12.7 | -10 | -3.19 |
Net Income Before Extraordinary Items | |||||
Net Income | 9.23 | -5.5 | -12.7 | -10 | -3.19 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9.23 | -5.5 | -12.7 | -10 | -3.19 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.04 | -0.02 | -0.027 | -0.03 | -0.009 |